Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,132 | 795 | 558 | 74 | -275 |
| Depreciation Amortization | 107 | 73 | 40 | 137 | 102 |
| Accounts receivable | -880 | -259 | -896 | -285 | -195 |
| Other Working Capital | -96 | 253 | -458 | -1,107 | -1,924 |
| Other Operating Activity | 1,152 | 454 | 1,078 | 689 | 496 |
| Operating Cash Flow | $1,415 | $1,316 | $322 | $-492 | $-1,796 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -50 | -50 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-50 | $-50 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -2 | -1 | -5 | -4 |
| Financing Cash Flow | $-4 | $-2 | $-1 | $-5 | $-4 |
| Beginning Cash Position | 3,760 | 3,760 | 3,760 | 4,307 | 4,307 |
| End Cash Position | 5,171 | 5,074 | 4,081 | 3,760 | 2,457 |
| Net Cash Flow | $1,411 | $1,314 | $321 | $-547 | $-1,850 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,415 | 1,316 | 322 | -492 | -1,796 |
| Capital Expenditure | N/A | N/A | N/A | -55 | -55 |
| Free Cash Flow | 1,415 | 1,316 | 322 | -547 | -1,851 |